IV Cefuroxime Dosing for 50kg 15-Year-Old Male with Moderate-Risk Pneumonia
For this 15-year-old patient with moderate-risk community-acquired pneumonia, administer IV cefuroxime 3750-5000 mg/day divided every 8 hours (1250-1667 mg every 8 hours), which translates to 75-100 mg/kg/day.
Dosing Calculation
For a 50 kg adolescent:
- Standard dose: 75-100 mg/kg/day divided every 6-8 hours 1
- Total daily dose: 3750-5000 mg/day
- Per dose (every 8 hours): 1250-1667 mg every 8 hours
- Per dose (every 6 hours): 938-1250 mg every 6 hours
Rationale and Clinical Context
The FDA-approved pediatric dosing for cefuroxime is 50-100 mg/kg/day in equally divided doses every 6-8 hours for most infections susceptible to cefuroxime 1. The higher end of this range (100 mg/kg/day) should be used for moderate-risk pneumonia, as this represents a more severe infection requiring robust coverage 1.
While the 2011 PIDS/IDSA guidelines [2-2] recommend third-generation cephalosporins (ceftriaxone 50-100 mg/kg/day or cefotaxime 150 mg/kg/day) as preferred agents for hospitalized children with community-acquired pneumonia, cefuroxime remains a reasonable alternative when these agents are unavailable or when local resistance patterns support its use. The guidelines emphasize ampicillin (150-200 mg/kg/day) for fully immunized children in areas with low penicillin resistance 2.
Practical Administration
- Route: Intravenous administration preferred for hospitalized patients with moderate-risk pneumonia 1
- Infusion: Administer over 3-5 minutes for direct IV injection, or through Y-type administration set 1
- Reconstitution: Each 1.5-gram vial should be constituted with 16 mL Sterile Water for Injection 1
Important Considerations
Maximum dose limitation: Do not exceed adult maximum dosing (1.5 grams every 8 hours for severe infections) 1. For this 50 kg patient, the calculated dose of 1250-1667 mg every 8 hours approaches or slightly exceeds the standard adult dose, so cap at 1500 mg every 8 hours.
Duration: Continue for minimum 48-72 hours after clinical improvement, with typical total course of 5-10 days 1. Consider transition to oral cefuroxime axetil (30 mg/kg/day in 2 divided doses, maximum 500 mg twice daily) once clinically stable 3, 4.
Target attainment concerns: Recent pharmacokinetic data suggest that standard cefuroxime dosing may result in suboptimal target attainment in pediatric patients, particularly those with augmented renal clearance 5. If clinical response is inadequate after 48-72 hours, consider switching to a third-generation cephalosporin as recommended by guidelines 2.
Renal function: This dosing assumes normal renal function. No adjustment needed for this patient unless renal impairment is present 1.